Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis

BACKGROUND: Bixalomer (BXL) was developed to improve gastrointestinal symptoms and reduce constipation, relative to sevelamer hydrochloride, in hemodialysis patients. We prospectively evaluated the safety and effectiveness of switching maintenance dialysis patients from sevelamer hydrochloride to BX...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Hatakeyama, Shingo, Murasawa, Hiromi, Narita, Takuma, Oikawa, Masaaki, Fujita, Naoki, Iwamura, Hiromichi, Mikami, Joutaro, Kojima, Yuta, Sato, Tendo, Fukushi, Ken, Ishibashi, Yusuke, Hashimoto, Yasuhiro, Koie, Takuya, Saitoh, Hisao, Funyu, Tomihisa, Ohyama, Chikara
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2013
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3852730/
https://ncbi.nlm.nih.gov/pubmed/24119202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-14-222
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים